- Services & Solutions
- Clients & Partners
Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group
SRI International, an independent nonprofit research and development institute, today announced that Joseph Perrone, Sc.D., has joined SRI’s International's Center for Advanced Drug Research (CADRE) in Shenandoah Valley, Virginia. In his new role, Dr. Perrone will head CADRE's molecular diagnostic efforts, including its rare and neglected diseases program.
Dr. Perrone is an experienced marketing and business development executive who has led global teams and developed successful strategic alliances. His leadership guided a team to develop pioneering instrumentation and rapid diagnostic tests for infectious and tropical diseases. Additionally, Dr. Perrone opened new markets and developed a profitable international business throughout Africa, Asia, Latin America and Europe.
"Joe Perrone is an accomplished manager, with exceptional ability to work closely with public health programs and bridge the gap between marketing and scientific challenges," said Krishna Kodukula, Ph.D., CADRE executive director. "His results-oriented approach and significant experience building creative and innovative teams will be an asset to SRI."
Prior to joining SRI, Dr. Perrone served as president of JBP Consulting. His past experience includes serving as Vice President of Strategic Initiatives and Business Development at the American Association for Clinical Chemistry and Vice President of Standards, Certification, and Product Development at American Type Culture Collection.
Earlier, he was Vice President of the Technology Transfer Office at the University of Maryland Biotechnology Institute. Dr. Perrone previously served as the Director of Business Development and R&D Team Manager at Becton Dickinson, where he was responsible for the rapid manual test business, technology assessment, and clinical trials in international markets.
Dr. Perrone received his Sc.D. from Johns Hopkins University and completed a postdoctoral fellowship at Harvard University. He has served as an advisor to the World Health Organization (WHO) and on the WHO diagnostic steering committee. He has received numerous marketing awards, including the R&D 100 award. Dr. Perrone has also served on the boards of FASGen and Legacy Direct, and is an advisor to Instantlabs.